| |
| |
|
| Insider
Information: |
Crooke Stanley T |
| Relationship: |
Director, 10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,021 |
|
|
Indirect Shares
|
7,547,002 |
|
|
| Direct
Value |
$78,718 |
|
|
|
Indirect Value
|
$35,098,088 |
|
|
| Total
Shares |
7,549,023 |
|
|
| Total
Value |
$35,176,806 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Exec Chairman of the B... |
2021-01-26 |
2,021 |
2021-01-26 |
497,502 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
463 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 19
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2012-09-20 |
4 |
OE |
$5.25 |
$190,155 |
D/D |
30,000 |
20,538 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2012-09-20 |
4 |
S |
$15.01 |
$308,234 |
D/D |
(20,538) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2012-09-21 |
4 |
AS |
$14.06 |
$414,236 |
D/D |
(29,462) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2012-09-21 |
4 |
OE |
$6.84 |
$201,520 |
D/D |
29,462 |
29,462 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2012-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
6,299,500 |
6,299,500 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • • |
2012-10-10 |
4 |
B |
$4.00 |
$3,000,000 |
I/I |
750,000 |
7,049,500 |
2.25 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,978 |
2,978 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-01-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
317 |
317 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-01-16 |
4 |
S |
$14.00 |
$18,438 |
D/D |
(1,317) |
1,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-01-16 |
4 |
S |
$14.00 |
$2,002 |
I/I |
(143) |
174 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-04-19 |
4 |
AS |
$20.01 |
$600,180 |
D/D |
(30,000) |
1,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-04-19 |
4 |
OE |
$7.26 |
$217,800 |
D/D |
30,000 |
31,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-04-22 |
4 |
OE |
$7.26 |
$145,200 |
D/D |
20,000 |
21,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-04-22 |
4 |
AS |
$20.99 |
$419,800 |
D/D |
(20,000) |
1,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-04-22 |
4 |
AS |
$20.99 |
$209,900 |
I/I |
(10,000) |
865,391 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-04-23 |
4 |
AS |
$22.10 |
$662,901 |
I/I |
(30,000) |
835,391 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
• • – |
2013-04-24 |
4 |
AS |
$22.12 |
$221,200 |
I/I |
(10,000) |
825,391 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-06-24 |
4 |
AS |
$25.16 |
$755,624 |
I/I |
(30,000) |
795,391 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-06-25 |
4 |
AS |
$27.87 |
$840,698 |
D/D |
(30,000) |
1,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-06-25 |
4 |
OE |
$6.81 |
$204,300 |
D/D |
30,000 |
21,226 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-06-26 |
4 |
OE |
$6.81 |
$136,200 |
D/D |
20,000 |
21,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-06-26 |
4 |
AS |
$27.10 |
$542,020 |
D/D |
(20,000) |
1,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-06-26 |
4 |
AS |
$26.70 |
$267,000 |
I/I |
(10,000) |
785,391 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-06-27 |
4 |
OE |
$6.81 |
$136,200 |
D/D |
20,000 |
11,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-06-27 |
4 |
AS |
$27.40 |
$557,000 |
D/D |
(20,000) |
1,661 |
0 |
- |
|
463 Records found
|
|
Page 6 of 19 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
